Poggio M. et al. reported similar findings in a mouse model of prostate cancer resistant to anti-PD-L1 therapy, using GW4869 treatment to suppress tumor growth by blocking the secretion of immunosuppressive exosomes [6]. This evidence concerns the gene CD274 and prostate cancer.